Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Making unresectable hepatic colorectal metastases resectable--does it work?

Jean-Nicolas Vauthey1, Daria Zorzi, Timothy M Pawlik

  • 1Department of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. jvauthey@mdanderson.org

Seminars in Oncology
|January 10, 2006
PubMed
Summary

Surgical resection offers 40-58% 5-year survival for colorectal liver metastases. Modern techniques enable extended hepatectomy for bilobar disease, improving outcomes when combined with strategies like portal vein embolization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late Effects of Chemotherapy on Patient-Reported Neuropathy, Balance Problems, and Fall Outcomes Among Older Breast Cancer Survivors.

JCO oncology practice·2026
Same author

Self-reported cognitive function in older breast cancer survivors after chemotherapy treatment.

Breast (Edinburgh, Scotland)·2025
Same author

Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment.

Cancer medicine·2023
Same author

A novel simple three-level liver resection classification without compromising the performance to predict surgical and postoperative outcomes.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2021
Same author

Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2021
Same author

Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2021

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Colorectal liver metastases (CLM) are a common challenge in oncology.
  • Surgical resection is the primary curative treatment for CLM.
  • Survival rates for surgical resection range from 40% to 58%.

Purpose of the Study:

  • To review current strategies for surgical resection of CLM.
  • To discuss the evolving definition of resectability in CLM.
  • To highlight advanced surgical techniques for bilobar CLM.

Main Methods:

  • Review of surgical literature on CLM resection.
  • Discussion of extended hepatectomy and its indications.
  • Exploration of neoadjuvant therapies and liver-sparing techniques.

Related Experiment Videos

Main Results:

  • Resectability criteria have expanded to include any number of metastases with negative margins.
  • Extended hepatectomy is feasible for bilobar CLM with low mortality.
  • Portal vein embolization can augment liver remnant volume for safe resection.

Conclusions:

  • Surgical resection remains the treatment of choice for CLM.
  • Advanced hepatectomy techniques and neoadjuvant strategies improve resectability for bilobar disease.
  • Multimodality approaches, including portal vein embolization, are crucial for optimizing outcomes.